Application of Physiologically-based Pharmacokinetic (PBPK) Modeling for Prediction of the Exposure of Buprenorphine in Neonates: Incorporation of CYP3A4 and UGT1A1 Ontogenies 2015 年 3 月 3 日 By webdev
Application of PBPK and Bayesian Modeling for Prediction of the Likelihood of Individual Patients Experiencing Serious Adverse Reactions to a Standard Dose of Efavirenz 2015 年 3 月 3 日 By webdev
Integrated Pharmacogenomic Analysis Reveals OATP1B1 T521C Polymorphism (rs4149056) Does Not Affect the Pharmacokinetics of Edoxaban 2015 年 3 月 3 日 By webdev
Simulating Cardiac Consequences of the Genetic Variability at the Metabolism Level with Use of Middle-out Approach and Flecainide as an Example Compound 2015 年 3 月 3 日 By webdev
A Model Relating Overall Survival Related to Tumor Growth Inhibition in Renal Cell Carcinoma Patients Treated with Sunitinib, Axitinib or Temsirolimus 2015 年 3 月 3 日 By webdev